Home › IGA Glomerulonephritis › Michigan
IGA Glomerulonephritis clinical trials in Michigan
5 studies for IGA Glomerulonephritis are looking for participants at sites in Michigan.
A Study to Evaluate the Effect of ARGX-121 on the Change in Proteinuria in Adult Participants With IgAN
- Michigan Kidney Consultants, Pontiac
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 27, 2026 · NCT07773727Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease
- ADARx Clinical Site, Shelby
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 20, 2026 · NCT06989359A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)
- Henry Ford Hospital, Detroit
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 14, 2026 · NCT06935357Study of BHV-1400 in IgA Nephropathy
- Site-015, Shelby
RecruitingPhase 1
Ages 18 to 65 · All sexes · Updated Jun 23, 2026 · NCT07054684Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
- C.S. Mott Children's Hospital, Ann Arbor
RecruitingPhase 2
Ages 1 to 17 · All sexes · Updated May 12, 2026 · NCT05003986From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.